Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin vs Gabapentin for Neuropathic Pain in Failed Back Surgery Syndrome
NCT05324761Phase 4Completed
- Sponsor
- Al-Kindy College of Medicine
- Start
- Apr 2022
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in neuropathic pain comparing Pregabalin with Gabapentin (2 arms). Primary endpoint: Efficacy in Neuropathic pain management at 1 month. Started Apr 2022; status: completed.
02
Drugs
pregabalingabapentin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT05324761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05324761.